James Stocks

机构：Center for Clinical Research (United States), The University of Texas Health Science Center at Tyler

发表论文 48 篇 · 总被引 3305 次 · h-index 21

代表论文

Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial (2015 · The Lancet · 被引 509)
The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult (2016 · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · 被引 218)
Serum VEGF-D concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial (2013 · The Lancet Respiratory Medicine · 被引 201)
Circulating polymers in α 1 -antitrypsin deficiency (2014 · European Respiratory Journal · 被引 88)
Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis (2019 · European Respiratory Journal · 被引 66)
Safety and Pharmacokinetics of 120 mg/kg versus 60 mg/kg Weekly Intravenous Infusions of Alpha-1 Proteinase Inhibitor in Alpha-1 Antitrypsin Deficiency: A Multicenter, Randomized, Double-Blind, Crossover Study (SPARK) (2013 · COPD Journal of Chronic Obstructive Pulmonary Disease · 被引 63)